In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells

Cornea

Volumn 22, Issue 5, 2003, Pages 468-472

  Scuderi, Anna Claudia ^a   Paladino, Grazia Maria ^b   Marino, Clara ^b   Trombetta, Francesco ^b  

^a SIFI SpA   (Italy)

^b NONE

Author keywords

Cornea; Cytotoxicity; Epithelium; Nefilmicin; Ofloxacin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; NETILMICIN; OFLOXACIN;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG CYTOTOXICITY; DRUG SAFETY; IN VITRO STUDY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CELL LINE; CELL SURVIVAL; EPITHELIUM, CORNEAL; MICROSCOPY, PHASE-CONTRAST; NETILMICIN; OFLOXACIN; OSMOLAR CONCENTRATION; RABBITS;

EID: 0037974683     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200307000-00014     Document Type: Article

References (40)

1. American Academy of Ophthalmology. Bacterial Keratitis. Preferred Practice Pattern™. Chicago: AAO, 2000.
2. Gwon A. Ofloxacin vs tobramycin for the treatment of external ocular infections. Archive of Ophthalmology. 1992;110:1234-1237
3. Wilhelmus KR, Gilbert ML, Osato MS. Tobramycin in ophthalmology. Surv Ophthalmol. 1987;32:111-112.
4. Records RE. Gentamicin in ophthalmology. Surv. Ophthalmol. 1976;21:49-58.
5. Seitz B, Hayashi S, Wee WR, et al. In vitro effects of aminoglycosides and fiuorofluoroquinolones on keratocytes. Invest Ophthalmol Vis Sci. 1996;37:656-665.
6. Mc Donald RH, Schatz H, Johnson RN, et al. Aminoglycoside toxicity. Semin Ophthalmol. 1993;8:136-143.
7. Alfonso EC, Albert DM, Kenyon KR, et al. In vitro toxicity of gentamicin to corneal epithelial cells. Cornea. 1990;9:55-61.
8. Lass JH, Mack RJ, Imperia PS, et al. An in vitro analysis of aminoglycoside corneal epithelial toxicity. Curr Eye Res. 1989;8:299-304.
9. Medin W. A method for registration of toxic drug effects on corneal endothelium. Effect of gentamicin on rabbit corneal endothelium. Acta Ophthalmol. 1992;70:101-107.
10. Petroutsos G., Savoldelli M., Pouliquen Y. The effect of gentamicin on the corneal endothelium. An experimental study. Cornea. 1990;9:62-65
11. Berry H, Gurung A.,Easty DL, et al. Toxicity of antibiotics and antifungals on cultured human corneal cells: effect of mixing, exposure and concentration. Eye. 1995;9:110-115.
12. Cutarelli PE, Lass JH, Lazarus HM, et al. Topical fluorofluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity. Curr Eye Res. 1991;10:557-563.
13. Matsumoto S., Stern ME. Effect of anti-infective ophthalmic solutions on corneal cells in vitro. Adv Ther. 2000;17:148-151.
14. Nakamura M, Nishida T, Mishima H, et al. Effects of antimicrobials on corneal epithelial migration. Curr Eye Res. 1993;12:733-740.
15. Petroutsos G, Guimaraes R, Giraud J, et al. Antibiotics and corneal epithelial wound healing. Arch Ophthalmol. 1983;101:1775-1778.
16. Stern GA, Schemmer GB, Farber RD, et al. Effect of topical antibiotic solutions on corneal epithelial wound healing. Arch Ophthalmol. 1983;101:644-647.
17. Madhavan HN, Rao SK, Joseph PR, et al. Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution. Cornea. 1999;18:549-552.
18. John T. Scanning electron microscopic study of a ciloxan bottle blocked by ciprofloxacin crystals. Eye. 2001;15:786-788.
19. Konishi M., Yamada M, Mashima Y. Corneal ulcer associated with deposits of norfloxacin. Am. J. Ophthalmol. 1998;125:258-260.
20. Eiferman RA, Snyder JP, Nordquist RE, et al. Ciprofloxacin microprecipitates in the human corneal epithelium. J Cataract Refract Surg. 2001;27:1701-1702.
21. Moreira LB, Lee RF. Effect of topical fluorofluoroquinolones on corneal re-epithelialization after excimen laser keratectomy. J Cataract Refract Surg. 1997;23:845-848.
22. Bekoe NA, Li Q, Ashrof F, et al. Effects of ciprofloxacin, ofloxacin and gentamicin on corneal cells and wound healing. Invest Ophthalmol Vis Sci. 1999;40:4.
23. Mallari PL, McCarty DJ, Daniele M, et al. Increased incidence of corneal perforation after topical fluorofluoroquinolone treatment for microbial keratitis. Am. J. Ophthalmol. 2001;131:131-133.
24. Papa V, Aragona P, Scuderi AC, et al. Treatment of acute bacterial conjunctivitis with topical netilmicin. Cornea. 2002;21:43-47.
25. Milazzo G, Papa V, Castorcea B, et al. Topical netilmicin compared with tobramicin in the treatment of external ocular infections. Int J Clin Pharm Ther. 1999;37:243-248.
26. Papparella AM, De Girolamo N, Piroli C, et al. L'uso della netilmicina collirio nelle infezioni oculari in età pediatrica. Boll Ocul. 1994;73: 3-6.
27. Campoli-Richards DM, Chaplin S, Sayce R, et al. Netilmicin; a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1989;38:703-756.
28. Bonfiglio G, Scuderi AC, Russo G. Netilmicin: in vitro activity, time-kill evaluation and post-antibiotic effect on microorganisms isolated from ocular infections. Chemotherapy. 2001;47:117-122.
29. Begg EJ, Barclay M. Aminoglycosides - 50 years on. Br J Clin Pharm. 1995;39:597-605.
30. Blanco AR, Cannatelli M, Cufari S, et al. Comparative in vitro activity of azythromicin, clarithromycin and erythromicin against contemporary clinical ocular isolates. Presented at: Third International Symposium on Ocular Pharmacology and Therapeutics, 2000, Lisbon.
31. Manorahan A, Lalitha M, Jeudason MV. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus. Natl Med J India. 1997;10:61-62.
32. Borenfreund E, Borrero O. In vitro cytotoxicity assays: potential alternatives to the Draize ocular allergy test. Cell Biol Toxicol. 1984;55-56.
33. Borenfreund E., Babich H, Martin-Alguacil N. Comparison of two in vitro cytotoxicity assays - the neutral red (NR) and tetrazolium MTT test. Toxic In Vitro. 1988;2:1-6.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
35. Lazarus HN, Imperia PS, Botti RE. An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agent. Lens Eye Toxic Res. 1989;6:59-85.
36. Tripathi BJ, Tripathi RC. Cytotoxic effect of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro. Lens Eye Toxic Res. 1989;6:395-403.
37. Paladino GM, Scuderi AC, Marino C. Effect of netilmicin formulations on corneal epithelial wound closure: In vitro and in vivo studies. ICER: International Congress of Eye Research-Geneva Switzerland Oct. 6-10, 2002.
38. Nelson JD, Silverman V, Lima PH, et al. Corneal epithelial wound healing: a tissue culture assay on the effect of antibiotics. Curr Eye Res. 1990;9:3.
39. Herting RL, Lorbar RR, Miller M, et al. Valutazione comparativa multicentrica sulla efficacia e sulla sicurezza della netilmicina e della gentamicina in pazienti adulti. Arzneim Forsch Drug Res. 1981;31:366.
40. Portoles M, Igual A, Jauch A. In vitro toxicity of lomefloxacin in rabbit corneal epithelial cell culture. Lens Eye Toxic Res. 1990;7:469-480.